BFB759
/ Bluefin Biomedicine
- LARVOL DELTA
Home
Next
Prev
1 to 6
Of
6
Go to page
1
July 31, 2026
COMPASS 2-AD: A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis
(clinicaltrials.gov)
- P2 | N=225 | Active, not recruiting | Sponsor: Bluefin Biomedicine, Inc. | Recruiting ➔ Active, not recruiting
Enrollment closed • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
May 25, 2026
CL-BFB759-002: A Study Evaluating BFB759 in Atopic Dermatitis
(clinicaltrialsregister.eu)
- P1/2 | N=88 | Active, not recruiting | Sponsor: Bluefin Biomedicine Inc. | Recruiting ➔ Active, not recruiting
Enrollment closed • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
April 02, 2026
CL-BFB759-003: A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
(clinicaltrialsregister.eu)
- P1/2 | N=36 | Not yet recruiting | Sponsor: Bluefin Biomedicine Inc.
New P1/2 trial • Dermatology • Hidradenitis Suppurativa • Immunology
February 18, 2026
CL-BFB759-002: A Study Evaluating BFB759 in Atopic Dermatitis
(clinicaltrialsregister.eu)
- P1/2 | N=118 | Recruiting | Sponsor: Bluefin Biomedicine Inc.
New P1/2 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
March 02, 2026
CL-BFB759-002: A Study Evaluating BFB759 in Atopic Dermatitis
(clinicaltrialsregister.eu)
- P1/2 | N=94 | Recruiting | Sponsor: Bluefin Biomedicine Inc.
New P1/2 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
December 18, 2025
COMPASS 2-HS: A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
(clinicaltrials.gov)
- P2/3 | N=210 | Recruiting | Sponsor: Bluefin Biomedicine, Inc.
New P2/3 trial • Dermatology • Hidradenitis Suppurativa • Immunology
1 to 6
Of
6
Go to page
1